000			02736nam a22003257a 4500
001			Undergraduate Ethical Clearance Certificate No. 019/2014
003			Undergraduate Ethical Clearance Certificate No. 019/2014
005			20240305193817.0
008			210731b |||||||| |||| 00| 0 eng d
028			_bWurzburg Road 35, BMC Premises, Post Code: 33102:
028			_bP. O Box 1464, Mwanza – Tanzania:
028			_bPhone: +255 28 298 3384:
028			_bFax: +255 28 298 3386:
028			_bEmail: vc@bugando.ac.tz :
028			_b www.bugando.ac.tz
035			_aUndergraduate Ethical Clearance Certificate No. 019/2014
040			_bEnglish _cDDC
041			_aEnglish
041			_aKiswahili
100			_a Kilamlya, Fred. Nelson _920184 _dUndergraduate Ethical Clearance Certificate No. 019/2014
245			_a Knowledge and Practices for SP Use in Intermittent Presumptive Treatment (IPT-sp) of Malaria Among Pregnant Women at Bugando Medical Centre.
260			_aMwanza, Tanzania: _bCatholic University of Health and Allied Sciences [CUHAS – Bugando] : _c ©2014
300			_a32 Pages
300			_aIncludes References
520			_aAbstract: Background: The standard treatment guideline of Tanzania mainland which was released in 2007 indicated that Artemether-Lumefantrine (ALU) should be used as the first line for malaria treatment instead of Sulphadoxine-Pyrimethamine (SP) with this change it was still advocated that pregnant women should continue to take SP for Intermittent Preventive Treatment (IPT) of malaria during pregnancy. Hence, despite increasing prevalence of malaria parasite resistance to SP, SP continues to be recommended for intermittent preventive treatment in pregnancy (IPTp). Method: The study was conducted from May 2014 to July 2014 at Bugando medical centre. Three hundred and eighty four (384) pregnant women were interviewed. Results: About (33.3%, n=128) of pregnant women did not know if SP was used for IPT. Most women (56.8%, n=218) did not know the use of SP for IPT in relationship with gestation age, only (8.6%, n=33) mentioned three doses of SP are acquired for a pregnant women and (59.4%, n=228) did not know the interval between one dose to another. One hundred seventy seven (46.1%, n=177) pregnant women reported to have had malaria during their current pregnancies. Conclusion: Most pregnant women had minimum knowledge about the use and benefits of SP for IPT. For effective implementation of IPT policy, pregnant women should be sensitized and educated on the use and benefits of SP for IPT.
600			_xPharmacy
600			_xObstetrics and Gynecology
700			_a Matovelo, Dismas _920052
942			_2ddc _cCR
999			_c20365 _d20365